Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/14712598.2021.1942833 http://scihub22266oqcxt.onion/10.1080/14712598.2021.1942833 34116611!ä!34116611 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\34116611.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Expert+Opin+Biol+Ther 2022 ; 22 (1): 17-29 Nephropedia Template TP {{tp|p=34116611|t=2022. IBD goes home: from telemedicine to self-administered advanced therapies |pdf=|usr=}}{{34116611}} gab.com Text IBD goes home: from telemedicine to self-administered advanced therapies JO: Expert Opin Biol Ther http://www.kidney.de/pget.php?&tw=1&pmid=34116611 #FOAvip INTRODUCTION: Major challenges have been posed by the coronavirus disease 2019 pandemic in the routine management of patients with inflammatory bowel disease (IBD). The need for constant monitoring of diseases activity and prompt adjustment of therapy have been balanced with the risk of contagion related to face-to-face consultations. Therefore, digital health initiatives have been pursued for safety reasons as vicarious instruments to avoid overcrowding of the IBD clinics. However, concerns and skepticism about the feasibility of digital health and telemedicine modalities limited their uptake in clinical practice in the pre-pandemic period. AREAS COVERED: We conducted a literature overview on the current state of the art and the potential future benefits deriving from the integration of telemedicine systems, home-based laboratory tests, and self-administered drugs into IBD daily practice. EXPERT OPINION: Digital health and telemedicine approaches at distance have been experimented as effective tools to avoid overcrowding of clinics and reduce risk from SARS-CoV2 exposure. Home-based point of care testing, such as fecal calprotectin and dried blood samples, might represent an effective method of remote monitoring of patients particularly when in-person visits are precluded. High expectations are placed on the use of self-administered advanced therapies, such as new subcutaneous formulation of biologics. Twit Text FOAVip IBD goes home: from telemedicine to self-administered advanced therapies ????Expert Opin Biol Ther http://www.kidney.de/pget.php?&tw=1&pmid=34116611 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=34116611 #FOAvip English Wikipedia <ref>{{Cite pmid|34116611}}</ref> IBD goes home: from telemedicine to self-administered advanced therapies #MMPMID34116611 Solitano V; Alfarone L; D'Amico F; Peyrin-Biroulet L; Danese S Expert Opin Biol Ther 2022[Jan]; 22 (1): 17-29 PMID34116611show ga INTRODUCTION: Major challenges have been posed by the coronavirus disease 2019 pandemic in the routine management of patients with inflammatory bowel disease (IBD). The need for constant monitoring of diseases activity and prompt adjustment of therapy have been balanced with the risk of contagion related to face-to-face consultations. Therefore, digital health initiatives have been pursued for safety reasons as vicarious instruments to avoid overcrowding of the IBD clinics. However, concerns and skepticism about the feasibility of digital health and telemedicine modalities limited their uptake in clinical practice in the pre-pandemic period. AREAS COVERED: We conducted a literature overview on the current state of the art and the potential future benefits deriving from the integration of telemedicine systems, home-based laboratory tests, and self-administered drugs into IBD daily practice. EXPERT OPINION: Digital health and telemedicine approaches at distance have been experimented as effective tools to avoid overcrowding of clinics and reduce risk from SARS-CoV2 exposure. Home-based point of care testing, such as fecal calprotectin and dried blood samples, might represent an effective method of remote monitoring of patients particularly when in-person visits are precluded. High expectations are placed on the use of self-administered advanced therapies, such as new subcutaneous formulation of biologics. |*COVID-19[MESH] |*Inflammatory Bowel Diseases[MESH] |*Telemedicine[MESH] |Humans[MESH] |RNA, Viral[MESH]IBD goes home: from telemedicine to self-administered advanced therapi(epmc).pdf DeepDyve Pubget Overpricing